LMAT vs TECH · P/E 35, rev $219.9M vs P/E 65, rev $1.22B
LeMaitre Vascular Inc (LMAT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the LMAT and TECH stock pages for the full models.
Not investment advice.